Ebanga
E468968
Ebanga is a monoclonal antibody drug used to treat Zaire ebolavirus infection (Ebola virus disease).
All labels observed (1)
| Label | Occurrences |
|---|---|
| Ebanga canonical | 3 |
How this entity was disambiguated
This entity first appeared as the object of triple T4784968 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ebanga Context triple: [mAb114, hasBrandName, Ebanga]
-
A.
Benina
Benina is a town in eastern Libya that serves as the main gateway to the nearby city of Benghazi through its international airport.
-
B.
Ewondo
Ewondo is a Bantu language spoken primarily by the Ewondo people in central Cameroon, including in and around the capital city, Yaoundé.
-
C.
Eyamba
Eyamba is a prominent clan of the Efik people of southeastern Nigeria, historically associated with leadership and influence in the Old Calabar region.
-
D.
Dutsin-Ma
Dutsin-Ma is a town in northern Nigeria known for hosting the Federal University Dutsin-Ma and serving as an important local commercial and educational center.
-
E.
Cacongo
Cacongo is a coastal town and municipality in Angola’s oil-rich Cabinda exclave, known historically as a trading port on the Atlantic coast.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ebanga Target entity description: Ebanga is a monoclonal antibody drug used to treat Zaire ebolavirus infection (Ebola virus disease).
-
A.
Benina
Benina is a town in eastern Libya that serves as the main gateway to the nearby city of Benghazi through its international airport.
-
B.
Ewondo
Ewondo is a Bantu language spoken primarily by the Ewondo people in central Cameroon, including in and around the capital city, Yaoundé.
-
C.
Eyamba
Eyamba is a prominent clan of the Efik people of southeastern Nigeria, historically associated with leadership and influence in the Old Calabar region.
-
D.
Dutsin-Ma
Dutsin-Ma is a town in northern Nigeria known for hosting the Federal University Dutsin-Ma and serving as an important local commercial and educational center.
-
E.
Cacongo
Cacongo is a coastal town and municipality in Angola’s oil-rich Cabinda exclave, known historically as a trading port on the Atlantic coast.
- F. None of above. chosen
Statements (29)
| Predicate | Object |
|---|---|
| instanceOf |
antiviral drug
ⓘ
biologic medicinal product ⓘ monoclonal antibody ⓘ |
| administrationSetting | hospital or clinical setting ⓘ |
| approvalYear | 2020 ⓘ |
| ATCCode | J06BD ⓘ |
| belongsTo | Ebola virus disease treatments ⓘ |
| countryOfApproval |
United States
ⓘ
linked to:
United States of America
|
| developedFor | treatment of Ebola virus disease caused by Zaire ebolavirus ⓘ |
| dosageForm | solution for intravenous infusion ⓘ |
| drugClass | monoclonal antibodies against infectious agents ⓘ |
| hasGenericName | ansuvimab ⓘ |
| indicatedFor | treatment of infection caused by Zaire ebolavirus (EBOV) ⓘ |
| indicatedPopulation | patients with laboratory-confirmed Zaire ebolavirus infection ⓘ |
| isHumanMonoclonalAntibody | true ⓘ |
| legalStatus | Rx-only in the United States ⓘ |
| mechanismOfAction | binds to Zaire ebolavirus glycoprotein and neutralizes the virus ⓘ |
| origin | human monoclonal antibody ⓘ |
| pharmacologicalEffect | virus neutralization ⓘ |
| prescriptionStatus | prescription only ⓘ |
| regulatoryAgencyApproval |
U.S. Food and Drug Administration
ⓘ
linked to:
Food and Drug Administration
|
| routeOfAdministration | intravenous infusion ⓘ |
| target |
Zaire ebolavirus glycoprotein
ⓘ
linked to:
Ebola virus glycoprotein
|
| therapeuticArea |
infectious diseases
ⓘ
virology ⓘ |
| therapyType | single monoclonal antibody therapy ⓘ |
| treats |
Ebola virus disease
ⓘ
Zaire ebolavirus infection ⓘ |
| usedIn | outbreaks of Ebola virus disease caused by Zaire ebolavirus ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Ebanga Description of subject: Ebanga is a monoclonal antibody drug used to treat Zaire ebolavirus infection (Ebola virus disease).
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.